Concepedia

Nanda Kumar Parvathaneni

NK

Statistics

Publications

4

Citations

163

H-Index

4

Active since

2013

Affiliations

Centre National de la Recherche Scientifique(Current)

University of Florence

Maastricht University Medical Centre

Institut des Biomolécules Max Mousseron

Université de Montpellier

Nanda Kumar Parvathaneni is an author at Centre National de la Recherche Scientifique specializing in radiation oncology, pharmacotherapy, and tumor biology.

Top concepts

Publications per year

2013–2019

4

Publications

4

Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: A new concept of dual targeting drugs

Ludwig J. Dubois, Sarah G.J.A. Peeters, Sander M. J. van Kuijk et al. · Radiotherapy and Oncology · 2013 · 92 citations · Full text

Design, synthesis, <i>in vitro</i> inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series

Ashok Aspatwar, Nanda Kumar Parvathaneni, Harlan Barker et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 26 citations · Full text

New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs

Sander M. J. van Kuijk, Nanda Kumar Parvathaneni, Raymon Niemans et al. · European Journal of Medicinal Chemistry · 2016 · 25 citations · Full text

, , +16

Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in<i>Xenopus</i>oocytes

Ashok Aspatwar, Holger M. Becker, Nanda Kumar Parvathaneni et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2018 · 20 citations · Full text

1–4 of 4